Related Experiment Video

Updated: Aug 4, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Therapeutic strategies for coronary artery disease beyond low density lipoprotein (LDL)--lowering

Y Arad1, U Saxena

  • 1Preventive Cardiology, St. Francis Hospital, Roslyn, New York 11576, USA.

Current Pharmaceutical Design
|March 6, 1999
PubMed

Insights

Coronary artery disease (CAD) treatments targeting cholesterol are insufficient for all patients. This review explores natural pathways, like nitric oxide and high-density lipoprotein, as potential next-generation therapies for atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Biochemistry

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality globally.
  • Current lipid-lowering drugs for CAD manage plasma cholesterol but may not benefit all at-risk populations.
  • An unmet medical need exists for more effective CAD therapeutics.

Purpose of the Study:

  • To review the nitric oxide (NO) pathway and high-density lipoprotein (HDL) system as potential therapeutic strategies for CAD.
  • To explore natural defense mechanisms against atherosclerosis for novel treatment development.

Main Methods:

  • Literature review of existing research on the nitric oxide pathway.
  • Analysis of the high-density lipoprotein system's role in atherosclerosis.
  • Evaluation of these natural paradigms as potential next-generation CAD therapeutics.

Main Results:

  • The nitric oxide pathway plays a crucial role in vascular function and has shown potential in managing atherosclerosis.
  • The high-density lipoprotein system demonstrates protective effects against atherosclerosis development and progression.
  • Both pathways represent promising targets for novel CAD therapies beyond cholesterol reduction.

Conclusions:

  • The nitric oxide pathway and HDL system offer promising avenues for developing next-generation therapeutics against coronary artery disease.
  • Targeting these natural mechanisms could address the limitations of current cholesterol-lowering strategies.
  • Further research into these paradigms may lead to more comprehensive treatments for atherosclerosis and CAD.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...